Literature DB >> 18565906

Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.

Allan J Pantuck, Tobias Klatte, David Seligson, Michael Atkins, Arie Belldegrun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18565906     DOI： 10.1200/JCO.2008.16.1935

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).

Authors:  Toni K Choueiri; Suchun Cheng; Angela Q Qu; Jaromir Pastorek; Michael B Atkins; Sabina Signoretti
Journal:  Urol Oncol       Date:  2012-11-07       Impact factor: 3.498

2.  [Gender-specific characteristics and survival of renal cell carcinoma].

Authors:  A J Schrader; S Sevinc; P J Olbert; A Hegele; Z Varga; R Hofmann
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

3.  Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma.

Authors:  Enyang Zhao; Lihong Li; Wenfu Zhang; Wanhui Wang; Yunhui Chan; Bosen You; Xuedong Li
Journal:  J Transl Med       Date:  2019-05-27       Impact factor: 5.531

4.  Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.

Authors:  Yinmin Gu; Yi Ming Zou; Danqing Lei; Yuanjie Huang; Weidong Li; Zengnan Mo; Yanling Hu
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.